SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-008347
Filing Date
2021-06-16
Accepted
2021-06-16 16:29:45
Documents
13
Period of Report
2021-06-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20210611x8k.htm   iXBRL 8-K 67511
2 EX-10.1 omer-20210611xex10d1.htm EX-10.1 155699
  Complete submission text file 0001558370-21-008347.txt   369882

Data Files

Seq Description Document Type Size
3 EX-101.SCH omer-20210611.xsd EX-101.SCH 3203
4 EX-101.LAB omer-20210611_lab.xml EX-101.LAB 15499
5 EX-101.PRE omer-20210611_pre.xml EX-101.PRE 10530
6 EXTRACTED XBRL INSTANCE DOCUMENT omer-20210611x8k_htm.xml XML 4670
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 211021848
SIC: 2834 Pharmaceutical Preparations